Adjuvant leuprolide with or without docetaxel in patients with high-risk prostate cancer after radical prostatectomy (TAX-3501): Important lessons for future trials
Michael T. Schweizer, Peng Huang, Michael W. Kattan, Adam S. Kibel, Ronald De Wit, Cora N. Sternberg, Jonathan I. Epstein, Mario A. Eisenberger
Dive into the research topics of 'Adjuvant leuprolide with or without docetaxel in patients with high-risk prostate cancer after radical prostatectomy (TAX-3501): Important lessons for future trials'. Together they form a unique fingerprint.